# Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance

> **NCT03769766** · PHASE3 · RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 291 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Curcumin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03769766
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-11
- **Primary completion:** 2029-11
- **Final completion:** 2030-11
- **Target enrollment:** 291 (ESTIMATED)
- **Last updated:** 2025-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03769766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03769766, "Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03769766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*